Discovery and pharmacological evaluation of growth hormone secretagogue receptor antagonists

被引:41
作者
Xin, Zhili [1 ]
Serby, Michael D. [1 ]
Zhao, Hongyu [1 ]
Kosogof, Christi [1 ]
Szczepankiewicz, Bruce G. [1 ]
Liu, Mei [1 ]
Liu, Bo [1 ]
Hutchins, Charles W. [1 ]
Sarris, Kathy A. [1 ]
Hoff, Ethan D. [1 ]
Falls, H. Douglas [1 ]
Lin, Chun W. [1 ]
Ogiela, Christopher A. [1 ]
Collins, Christine A. [1 ]
Brune, Michael E. [1 ]
Bush, Eugene N. [1 ]
Droz, Brian A. [1 ]
Fey, Thomas A. [1 ]
Knourek-Segel, Victoria E. [1 ]
Shapiro, Robin [1 ]
Jacobson, Peer B. [1 ]
Beno, David W. A. [1 ]
Turner, Teresa M. [1 ]
Sham, Hing L. [1 ]
Liu, Gang [1 ]
机构
[1] Abbott Labs, Metab Dis Res, Global Pharmaceut Res & Dev, Abbott Pk, IL 60064 USA
关键词
D O I
10.1021/jm060461g
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The discovery and pharmacological evaluation of potent, selective, and orally bioavailable growth hormone secretagogue receptor (GHS-R) antagonists are reported. Previously, 2,4-diaminopyrimidine-based GHS-R antagonists reported from our laboratories have been shown to be dihydrofolate reductase ( DHFR) inhibitors. By comparing the X-ray crystal structure of DHFR docked with our GHS-R antagonists and GHS-R modeling, we designed and synthesized a series of potent and DHFR selective GHS-R antagonists with good pharmacokinetic (PK) profiles. An amide derivative 13d (Ca2+ flux IC50) 188 nM, [brain]/[plasma]) = 0.97 @ 8 h in rat) showed a 10% decrease in 24 h food intake in rats, and over 5% body weight reduction after 14-day oral treatment in diet-induced obese (DIO) mice. In comparison, a urea derivative 14c (Ca2+ flux IC50) 7 nM, [brain]/[plasma]) = 0.0 in DIO) failed to show significant effect on food intake in the acute feeding DIO model. These observations demonstrated for the first time that peripheral GHS-R blockage with small molecule GHS-R antagonists might not be sufficient for suppressing appetite and inducing body weight reduction.
引用
收藏
页码:4459 / 4469
页数:11
相关论文
共 34 条
[11]  
Hutchins Charles, 1996, V39, P213
[12]   Ghrelin is a growth-hormone-releasing acylated peptide from stomach [J].
Kojima, M ;
Hosoda, H ;
Date, Y ;
Nakazato, M ;
Matsuo, H ;
Kangawa, K .
NATURE, 1999, 402 (6762) :656-660
[13]   Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor [J].
Kojima, M ;
Hosoda, H ;
Matsuo, H ;
Kangawa, K .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2001, 12 (03) :118-122
[14]  
KOJIMA M, 2000, PHYSIOL REV, V85, P495
[15]   Ghrelin: update on a novel hormonal system [J].
Korbonits, M ;
Grossman, AB .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2004, 151 :S67-S70
[16]   Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy [J].
le Roux, CW ;
Neary, NM ;
Halsey, TJ ;
Small, CJ ;
Martinez-Isla, AM ;
Ghatei, MA ;
Theodorou, NA ;
Bloom, SR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (08) :4521-4524
[17]   Optimization of 2,4-diaminopyrimidines as GHS-R antagonists: Side chain exploration [J].
Liu, B ;
Liu, M ;
Xin, ZL ;
Zhao, HY ;
Serby, MD ;
Kosogof, C ;
Nelson, LTJ ;
Szczepankiewicz, BG ;
Kaszubska, W ;
Schaefer, VG ;
Falls, HD ;
Lin, CW ;
Collins, CA ;
Sham, HL ;
Liu, G .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (07) :1864-1868
[18]   Novel isoxazole carboxamides as growth hormone secretagogue receptor (GHS-R) antagonists [J].
Liu, B ;
Liu, G ;
Xin, ZL ;
Serby, MD ;
Zhao, HY ;
Schaefer, VG ;
Falls, HD ;
Kaszubska, W ;
Collins, CA ;
Sham, HL .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (20) :5223-5226
[19]   A role for ghrelin in the central regulation of feeding [J].
Nakazato, M ;
Murakami, N ;
Date, Y ;
Kojima, M ;
Matsuo, H ;
Kangawa, K ;
Matsukura, S .
NATURE, 2001, 409 (6817) :194-198
[20]   SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF NOVEL BENZIMIDAZOLE AND IMIDAZO[4,5-B]PYRIDINE ACID-DERIVATIVES AS THROMBOXANE-A(2) RECEPTOR ANTAGONISTS [J].
NICOLAI, E ;
GOYARD, J ;
BENCHETRIT, T ;
TEULON, JM ;
CAUSSADE, F ;
VIRONE, A ;
DELCHAMBRE, C ;
CLOAREC, A .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (09) :1175-1187